User profiles for Andrea Matucci

Andrea Matucci

IRCCS Sacro Cuore Don Calabria Hospital (Negrar, Verona)
Verified email at sacrocuore.it
Cited by 287

Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent

…, L Ciani, L Gori, C Lazzeri, A Matucci… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Coronavirus disease 19 (COVID-19) is an emerging infectious disease
caused by SARS-CoV-2. Antiviral immune response is crucial to achieve pathogen clearance; …

Identification of a novel subset of human circulating memory CD4+ T cells that produce both IL-17A and IL-4

…, F Frosali, V Querci, R Angeli, A Matucci… - Journal of Allergy and …, 2010 - Elsevier
BACKGROUND: IL-17A has been suggested to play a pathogenic role in bronchial asthma
and other allergic disorders. OBJECTIVE: Study of the relationship between human IL-17A–…

Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis

…, L Moja, M Cinquini, V Marino, A Matucci… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: Five anti-tumor necrosis factor (anti-TNF) agents have received regulatory
approval for use in rheumatology: adalimumab, golimumab, infliximab, certolizumab, and …

[HTML][HTML] Eosinophils in health and disease: a state-of-the-art review

…, SK Dougan, S Berdnikovs, F Schleich, A Matucci… - Mayo Clinic …, 2021 - Elsevier
Eosinophils play a homeostatic role in the body’s immune responses. These cells are involved
in combating some parasitic, bacterial, and viral infections and certain cancers and have …

Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?

A Matucci, A Vultaggio, E Maggi, I Kasujee - Respiratory research, 2018 - Springer
Bronchial asthma (BA) is a chronic inflammatory disease with a marked heterogeneity in
pathophysiology and etiology. The heterogeneity of BA may be related to the inducing …

Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice

…, G Delogu, G Garlaschi, A Sanduzzi, A Matucci… - Autoimmunity …, 2015 - Elsevier
Since the introduction of biologics for the treatment of rheumatoid arthritis (RA), psoriatic arthritis
(PsA), ankylosing spondylitis (AS), and psoriasis (Pso) an increased risk of tuberculosis (…

[HTML][HTML] Oropouche fever cases diagnosed in Italy in two epidemiologically non-related travellers from Cuba, late May to early June 2024

C Castilletti, A Mori, A Matucci, N Ronzoni… - …, 2024 - eurosurveillance.org
Oropouche fever is caused by Oropouche virus (OROV), transmitted primarily through the
bite of infected midges, particularly of the genus Culicoides. The virus is mainly circulating in …

Systematic review of safety and efficacy of rituximab in treating immune-mediated disorders

…, UC Steiner, A Vultaggio, A Matucci… - Frontiers in …, 2019 - frontiersin.org
Background: During the past years biologic agents (also termed biologicals or biologics)
have become a crucial treatment option in immunological diseases. Numerous articles have …

Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: an EAACI statement

…, L Klimek, A Kolios, A Kothari, ML Kowalski, A Matucci… - Allergy, 2020 - Wiley Online Library
The outbreak of the SARS‐CoV‐2‐induced coronavirus disease 2019 (COVID‐19) pandemic
re‐shaped doctor‐patient interaction and challenged capacities of healthcare systems. It …

COVID‐19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.

A Matucci, M Caminati, E Vivarelli, A Vianello… - Allergy, 2021 - search.ebscohost.com
Andrea Matucci1 Marco Caminati2 Emanuele Vivarelli1 Andrea Vianello3 Claudio
Micheletto4 Francesco Menzella5 Ernesto Crisafulli6 Giovanni Passalacqua7 Diego Bagnasco7 …